General Announcement::Question and Answer Ahead of the Upcoming Extraordinary General Meeting to Be Held on 8 May 2026

Issuer & Securities

Issuer/ Manager
IX BIOPHARMA LTD.
Securities
IX BIOPHARMA LTD. - SG1BD9000009 - 42C
IX BIOPHARMA LTD. W260718 - SGXN57296778 - HQXW
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
02-May-2026 18:33:52
Status
New
Announcement Sub Title
Question and Answer Ahead of the Upcoming Extraordinary General Meeting to Be Held on 8 May 2026
Announcement Reference
SG260502OTHRIDGI
Submitted By (Co./ Ind. Name)
Gwendolin Lee Soo Fern
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)

Please see attached.

Attachments

EGM QnA Company responses 020526.pdf
Total size =33K